Myung S. Park

Dr. Myung S. Park is a Professor of Surgery at Mayo Clinic in Rochester, Minnesota, with joint appointments in Laboratory Medicine & Pathology and Hematology. She serves as Director of the Clinical Research and Trials Unit at the Center for Clinical and Translational Science (CCaTS) and Associate Medical Director for Basic Science Research at the Mayo Clinic Trauma Center.

Education:

• Basic Science Masters in Clinical and Translational Science, Mayo Clinic College of Medicine (2016)
• MS in Clinical and Translational Science, Mayo Clinic (2015)
• MD, State University of New York, Brooklyn (1995)
• BS in Chemistry and Molecular Biology, Long Island University (1991)

Her research focuses on trauma-induced coagulopathy and venous thromboembolism (VTE), utilizing biomarkers and translational approaches to improve patient outcomes. She investigates thrombin generation, resuscitation methods, and COVID-19 impacts on coagulation. Her work integrates the Rochester Epidemiology Project and Mayo Clinic's translational science resources.

Dr. Park's publications emphasize thromboinflammation, trauma biomarkers, and surgical critical care, with recent studies on murine injury models and hormonal impacts in COVID-19.

Awards & Honors:

• Shock Travel Award (2024)
• Top Trauma Paper, Minnesota Surgical Society (2024)
• U.S. Air Force Commendation Medal (2007)
• Arnold Schwartz Award for Excellence in Surgery (1995)

She leads NIH/DoD-funded projects on trauma coagulopathy and directs Mayo Clinic's translational research initiatives. Her lab at CCaTS focuses on converting scientific discoveries into clinical applications for trauma patients.